Skip to main content

Table 6 Comparison of clinical characteristics of patients with normal pregnancy and patients with recurrent CSP after CSP surgery

From: Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy

Characteristics

Normal pregnancy(n = 58)

Recurrent CSP(n = 17)

P

Age (years)

32.31 ± 4.19

32.47 ± 3.50

0.890

Number of prior pregnancies

3.50 ± 1.61

3.88 ± 1.17

0.116

Number of abortions

1.19 ± 1.29

1.24 ± 1.25

0.811

Number of prior cesarean delivery

1.07 ± 0.26

1.41 ± 0.49

0.000*

β-HCG level at diagnosis (mIU/mL)

48,781.43 ± 45,648.66

71,806.06 ± 65,291.07

0.333

Gestational sac size(cm)

2.72 ± 1.31

2.67 ± 1.00

0.834

Gestational age(days)

52.62 ± 8.82

56.18 ± 11.07

0.257

Presence of fetal heartbeat

  

0.845

 Yes

19(32.76)

6(35.29)

 

 No

39(67.24)

11(64.71)

 

Symptoms at diagnosis

  

0.001*

 Abdominal pain

2(3.45)

0(0.00)

 

 Vaginal bleeding

26(44.83)

7(41.18)

 

 Both

6(1.34)

4(23.53)

 

 None

24(41.38)

6(35.29)

 

Types of CSP

  

0.793

 I

31(53.45)

8(47.06)

 

 II

18(31.03)

7(41.18)

 

 III

9(15.52)

2(11.76)

 

Surgical treatment

  

0.292

 Hysteroscopic lesion excision

52(89.66)

13(76.47)

 

 Ultrasound-monitored curettage

4(6.90)

2(11.76)

 

 Laparoscopic lesion excision

1(1.72)

1(5.88)

 

 Transabdominal lesion excision

0

1(5.88)

 

 Transvaginal esion excision

1(1.72)

0

 

 UAE treatment

  

0.172

  Yes

9(15.52)

5(29.41)

 

  No

49(84.48)

12(70.59)

 

 Time since CSP treatment(Months)

19.07 ± 12.72

25.18 ± 20.05

0.322

  1. Data are n, mean ± SD, or n (%)
  2. CSP, cesarean scar pregnancy; β-HCG, Beta-human chorionic gonadotropin; UAE, uterine artery embolization
  3. “*” indicates a statistically significant difference